OptimizeRx Corporation (OTCMKTS:OPRX) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02 Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers.
Effective January 24, 2017, we have appointed Mr. James Lang as a
member of our Board of Directors.
Mr. Lang brings us more than 25 years of experience in healthcare
data, analytic, and technology enabled business services. Mr.
Lang presently serves as an executive advisor to Water Street, a
strategic private equity firm focused exclusively on building
market-leading companies in healthcare. He is also a director of
BioVie, a development-stage company pioneering an innovative
therapeutic that targets complications due to liver cirrhosis.
Mr. Lang previously served as CEO of Decision Resources Group, a
leading healthcare research and consulting company providing
high-value healthcare industry analysis and insights, where he
helped transform the company into an industry leader. Earlier, he
was president of Strategic Decisions Group, a premier global
strategy consultancy, and he expanded the life sciences practice
and later sold it to IMS Health. He is an active private investor
and advisor with healthcare companies, including Boston Heart
Diagnostics (acquired by Eurofins) and AlphalmpactRx (acquired by
IMS Health).
There were no arrangements or understandings between Mr. Lang and
any other persons to which such Mr. Lang was selected as a member
of our Board of Directors.
As a non-employee director, Mr. Lang will be entitled to
participate in our Director Compensation Plan.
We issued a press release on January 30, 2017 announcing the
appointment of Mr. Lang to our Board of Directors. A copy of the
press release is attached hereto as Exhibit 99.1.
SECTION 9 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits.
| Exhibit No. | Description |
| 99.1 | Press Release dated January 30, 2017 |
About OptimizeRx Corporation (OTCMKTS:OPRX)
OptimizeRx Corporation is a technology solutions company. The Company focuses on the healthcare industry. The Company connects patients, physicians and pharmaceutical manufacturers through technology. The Company’s solutions provide pharmaceutical manufacturers a direct to physician channel for communicating and promoting products. It provides healthcare providers a means to provide sampling and coupons without having to physically store samples on site. The Company’s principal products and applications include SampleMD, OPTIMIZEHR and OPTIMIZERx.com. SampleMD is a virtual Patient Support Center. OPTIMIZEHR is a consulting practice focused on educating and working with pharmaceutical manufacturers on identifying, formulating and implementing new electronic prescribing (eRx) media strategies for promoting their products. OPTIMIZERx.com is a portal to healthcare savings for patients to centrally review and participate in prescription and healthcare savings and support programs. OptimizeRx Corporation (OTCMKTS:OPRX) Recent Trading Information
OptimizeRx Corporation (OTCMKTS:OPRX) closed its last trading session 00.000 at 0.800 with 30,766 shares trading hands.
